High dimensional profiling of the immune microenvironment in smoldering multiple myeloma

被引：0

作者：

Cho, Hearn Jay ^{[1
]}

Fernandez, Nicolas ^{[2
]}

Perumal, Deepak ^{[3
]}

Rahman, Adeeb ^{[4
]}

Kim-Schulze, Seunghee ^{[4
]}

Auclair, Daniel ^{[5
]}

Adams, Homer, III ^{[6
]}

Parekh, Samir ^{[7
]}

Gnjatic, Sacha ^{[4
]}

机构：

[1] Icahn Sch Med Mt Sinai, Tisch Canc 1, New York, NY 10029 USA

[2] Mt Sinai, Icahn Sch Med, Human Immune Monitoring Ctr, New York, NY USA

[3] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA

[4] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA

[5] MMRF, Norwalk, CT USA

[6] Janssen Res & Dev, Spring House, PA USA

[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

immunotherapy; microenvironment; Smoldering Multiple Myeloma;

D O I：

10.1016/j.clml.2019.09.041

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OAB-040

引用

页码：E27 / E28

页数：2

共 50 条

[21] Thalidomide for previously untreated indolent or smoldering multiple myeloma [J].

Rajkumar, SV ;

Dispenzieri, A ;

Fonseca, R ;

Lacy, MQ ;

Geyer, S ;

Lust, JA ;

Kyle, RA ;

Greipp, PR ;

Gertz, MA ;

Witzig, TE .

LEUKEMIA, 2001, 15 (08) :1274-1276

[22] Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma [J].

Rajkumar, S. Vincent ;

Lacy, Martha Q. ;

Kyle, Robert A. .

BLOOD REVIEWS, 2007, 21 (05) :255-265

[23] The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective [J].

Caers, Jo ;

Fernandez de Larrea, Carlos ;

Leleu, Xavier ;

Heusschen, Roy ;

Zojer, Niklas ;

Decaux, Olivier ;

Kastritis, Efstathios ;

Minnema, Monique ;

Jurczyszyn, Artur ;

Beguin, Yves ;

Waesch, Ralph ;

Palumbo, Antonio ;

Dimopoulos, Meletios ;

Victoria Mateos, Maria ;

Ludwig, Heinz ;

Engelhardt, Monika .

ONCOLOGIST, 2016, 21 (03) :333-342

[24] Smoldering multiple myeloma: Integrating biology and risk into management [J].

Patel, Roshani ;

Hill, Elizabeth ;

Dhodapkar, Madhav .

SEMINARS IN HEMATOLOGY, 2025, 62 (01) :3-10

[25] Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma [J].

Sharma, Niyati Seshagiri ;

Choudhary, Bibha .

BIOMOLECULES, 2023, 13 (11)

[26] Treatment of Smoldering Multiple Myeloma: Ready for Prime Time? [J].

Kim, E. Bridget ;

Yee, Andrew J. ;

Raje, Noopur .

CANCERS, 2020, 12 (05)

[27] Treatment of high-risk smoldering myeloma [J].

Korde, Neha .

SEMINARS IN ONCOLOGY, 2016, 43 (06) :695-696

[28] Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditions [J].

Moscvin, Maria ;

Evans, Benjamin ;

Bianchi, Giada .

JOURNAL OF CANCER METASTASIS AND TREATMENT, 2023, 9

[29] The evolution of immune dysfunction in multiple myeloma [J].

Soekojo, Cinnie Yentia ;

Chng, Wee Joo .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (05) :415-424

[30] Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma [J].

Larsen, J. T. ;

Kumar, S. K. ;

Dispenzieri, A. ;

Kyle, R. A. ;

Katzmann, J. A. ;

Rajkumar, S. V. .

LEUKEMIA, 2013, 27 (04) :941-946

← 1 2 3 4 5 →